Latest Technology News

McLaren Minerals reports promising early Phase 1 drilling results at its McLaren Titanium Project, revealing high-grade heavy mineral assays beyond current resource boundaries and signaling strong potential for resource expansion.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

JAYRIDE Group has secured its first enterprise SaaS client with Thailand’s GB Limousine, marking a pivotal shift to recurring revenue and enterprise-grade transport software.

FBR Limited invites eligible shareholders to participate in a $1 million Share Purchase Plan at a 23.1% discount, aiming to fund key robotic projects and repay debt.

Kogan.com has recorded a significant non-cash goodwill impairment related to its Mighty Ape acquisition, reflecting ongoing challenges in New Zealand’s retail market and delayed technology recovery.

RocketDNA has secured a three-year contract to deploy its autonomous drone solution at the Gruyere Gold Mine, marking a significant step in integrating AI-powered surveying technology in mining operations.

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

Pure Resources reaffirms exceptional metallurgical results at its Garnet Hills Project, achieving garnet grades up to 98% through sustainable processing. The company is now scaling up testing and forging strategic collaborations in the US to unlock downstream rare earth opportunities.

Power Minerals reports compelling high-grade niobium and rare earth element intersections from early-stage auger drilling at its Santa Anna Project in Brazil, extending the known mineralised footprint and reinforcing confidence in a significant resource.

Rhythm Biosciences has announced a $3.75 million placement to accelerate the commercial launch of its ColoSTAT® cancer detection test and expand its geneType™ product suite into key markets. The capital raise includes director participation and attaching options, pending shareholder approval.

Rhythm Biosciences is raising up to $3.75 million through a share placement to fund the launch of its ColoSTAT® colorectal cancer diagnostic and accelerate commercialization of its geneType™ portfolio.

betr Entertainment Limited has launched a superior all-scrip takeover offer for PointsBet Holdings Limited, valuing PointsBet shares between $1.22 and $1.29 each and aiming to create Australia’s fourth largest online wagering operator. The deal promises substantial cost synergies and strategic growth opportunities.